A fluorescent version of the bradykinin B2 receptor antagonist B-9430: Pharmacological characterization and use in live cell imaging

This publication has 11 references indexed in Scilit:

• Lack of direct interaction between enalaprilat and the kinin B1 receptors
  Peptides, 2008
• B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) Is an Inactivation-Resistant Agonist of the Bradykinin B2 Receptor Derived from the Peptide Antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): Pharmacologic Profile and Effective Induction of Receptor Degradation
  The Journal of Pharmacology and Experimental Therapeutics, 2007
• Antagonist, partial agonist and antiproliferative actions of B‐9870 (CU201) as a function of the expression and density of the bradykinin B₁and B₂receptors
  British Journal of Pharmacology, 2007
• International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
  Pharmacological Reviews, 2005
• Bradykinin antagonist decreases early disruption of the blood–spinal cord barrier after spinal cord injury in mice
  Neuroscience Letters, 2001
• Bradykinin receptor antagonists type 2 attenuate the inflammatory changes in peptidoglycan-induced acute arthritis in the Lewis rat
  Inflammation Research, 2001
• Non‐competitive pharmacological antagonism at the rabbit B₁ receptor
  British Journal of Pharmacology, 2000
• Antagonist-Induced Intracellular Sequestration of Rabbit Bradykinin B₂Receptor
  Hypertension, 2000
• A new class of bradykinin antagonists containing indanylglycine
  Immunopharmacology, 1996
• A new generation of bradykinin antagonists
  Immunopharmacology, 1996